Nathan Caffo, Chief Business Officer at Candel Therapeutics, Inc. (CADL), bought 6,000 shares at $8.00 ($48K) on 2021-07-29, disclosed to the SEC on 2021-08-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.